As the global economy recovers in 2021 and the supply of the industrial chain improves, the Protein and Peptide Therapeutics market will undergo major changes. According to the latest research, the market size of the Protein and Peptide Therapeutics industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Protein and Peptide Therapeutics industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Protein and Peptide Therapeutics market during the next few years. The global Protein and Peptide Therapeutics market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The Protein and Peptide Therapeutics market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Highlights-Players
Major Players in Protein and Peptide Therapeutics market are:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Highlights-Types
Most important types of Protein and Peptide Therapeutics products covered in this report are:
Injection
Oral
Application listHighlights-Application
Most widely Application of Protein and Peptide Therapeutics market covered in this report are:
Cancer
Metabolic Disorders
Central Nervous System
Other
Table of Content
1 Protein and Peptide Therapeutics Market Scope Analysis Introduction
1.1 Product Definition and Scope Introduction of Protein and Peptide Therapeutics
1.2 Market by Type
1.2.1 Global Protein and Peptide Therapeutics Market Size Growth Rate by Typ
1.2.2 Global Protein and Peptide Therapeutics Market Type Definitio
1.3 Market by Application
1.3.1 Global Protein and Peptide Therapeutics Market Size Growth Rate by Application
1.3.2 Global Protein and Peptide Therapeutics Market Application Definition
1.4 Global Protein and Peptide Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Protein and Peptide Therapeutics Revenue 2017-2028
1.4.2 Global Protein and Peptide Therapeutics Sales 2017-2028
1.4.3 Protein and Peptide Therapeutics Market Size by Region: 2017 Versus 2022 Versus 2028
2 Analysis of Key Market Players
2.1 Global Protein and Peptide Therapeutics Sales by Players
2.1.1 Global Top Protein and Peptide Therapeutics Players by Sales (2017-2022)
2.1.2 Global Top Protein and Peptide Therapeutics Players Market Share by Sales (2017-2022)
2.1.3 Global Top 10 and Top 5 Companies by Protein and Peptide Therapeutics Sales in 2020
2.2 Global Protein and Peptide Therapeutics Revenue by Players
2.2.1 Global Top Protein and Peptide Therapeutics Players by Revenue (2017-2022)
2.2.2 Global Top Protein and Peptide Therapeutics Players Market Share by Revenue (2017-2022)
2.2.3 Global Top 10 and Top 5 Companies by Protein and Peptide Therapeutics Revenue in 2020
2.3 Mergers & Acquisitions, Expansion Plans
2.4 Sanofi
2.4.1 Sanofi Corporation Information
2.4.2 Sanofi Overview
2.4.3 Sanofi Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.4.4 Sanofi Protein and Peptide Therapeutics Product Description
2.4.5 Sanofi Protein and Peptide Therapeutics Related Developments
2.5 Teva
2.5.1 Teva Corporation Information
2.5.2 Teva Overview
2.5.3 Teva Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.5.4 Teva Protein and Peptide Therapeutics Product Description
2.5.5 Teva Protein and Peptide Therapeutics Related Developments
2.6 Novo Nordisk
2.6.1 Novo Nordisk Corporation Information
2.6.2 Novo Nordisk Overview
2.6.3 Novo Nordisk Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.6.4 Novo Nordisk Protein and Peptide Therapeutics Product Description
2.6.5 Novo Nordisk Protein and Peptide Therapeutics Related Developments
2.7 Takeda
2.7.1 Takeda Corporation Information
2.7.2 Takeda Overview
2.7.3 Takeda Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.7.4 Takeda Protein and Peptide Therapeutics Product Description
2.7.5 Takeda Protein and Peptide Therapeutics Related Developments
2.8 Eli Lilly
2.8.1 Eli Lilly Corporation Information
2.8.2 Eli Lilly Overview
2.8.3 Eli Lilly Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.8.4 Eli Lilly Protein and Peptide Therapeutics Product Description
2.8.5 Eli Lilly Protein and Peptide Therapeutics Related Developments
2.9 AstraZeneca
2.9.1 AstraZeneca Corporation Information
2.9.2 AstraZeneca Overview
2.9.3 AstraZeneca Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.9.4 AstraZeneca Protein and Peptide Therapeutics Product Description
2.9.5 AstraZeneca Protein and Peptide Therapeutics Related Developments
2.10 Novartis
2.10.1 Novartis Corporation Information
2.10.2 Novartis Overview
2.10.3 Novartis Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.10.4 Novartis Protein and Peptide Therapeutics Product Description
2.10.5 Novartis Protein and Peptide Therapeutics Related Developments
2.11 AbbVie
2.11.1 AbbVie Corporation Information
2.11.2 AbbVie Overview
2.11.3 AbbVie Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.11.4 AbbVie Protein and Peptide Therapeutics Product Description
2.11.5 AbbVie Protein and Peptide Therapeutics Related Developments
2.12 Ipsen
2.12.1 Ipsen Corporation Information
2.12.2 Ipsen Overview
2.12.3 Ipsen Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.12.4 Ipsen Protein and Peptide Therapeutics Product Description
2.12.5 Ipsen Protein and Peptide Therapeutics Related Developments
2.13 Ferring
2.13.1 Ferring Corporation Information
2.13.2 Ferring Overview
2.13.3 Ferring Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.13.4 Ferring Protein and Peptide Therapeutics Product Description
2.13.5 Ferring Protein and Peptide Therapeutics Related Developments
2.14 Merck
2.14.1 Merck Corporation Information
2.14.2 Merck Overview
2.14.3 Merck Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.14.4 Merck Protein and Peptide Therapeutics Product Description
2.14.5 Merck Protein and Peptide Therapeutics Related Developments
2.15 The Medicines
2.15.1 The Medicines Corporation Information
2.15.2 The Medicines Overview
2.15.3 The Medicines Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.15.4 The Medicines Protein and Peptide Therapeutics Product Description
2.15.5 The Medicines Protein and Peptide Therapeutics Related Developments
2.16 J & J
2.16.1 J & J Corporation Information
2.16.2 J & J Overview
2.16.3 J & J Protein and Peptide Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
2.16.4 J & J Protein and Peptide Therapeutics Product Description
2.16.5 J & J Protein and Peptide Therapeutics Related Developments
3 Protein and Peptide Therapeutics Historical and Forecast Market Size by Region
3.1 Global Protein and Peptide Therapeutics Historical and Forecast Sales Market Size by Region
3.2 Global Protein and Peptide Therapeutics Historical and Forecast Revenue Market Size by Region
3.3 {xx} Historical and Forecast Market Size by Country
3.3.1 {xx} Historical and Forecast Sales Market Size by Country (2017-2028)
3.3.2 {xx} Historical and Forecast Revenue Market Size by Country (2017-2028)
4 Market Size by Type
4.1 Global Protein and Peptide Therapeutics Sales by Type
4.1.1 Global Protein and Peptide Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Protein and Peptide Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Protein and Peptide Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Protein and Peptide Therapeutics Revenue by Type
4.2.1 Global Protein and Peptide Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Protein and Peptide Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Protein and Peptide Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Protein and Peptide Therapeutics Price by Type
4.3.1 Global Protein and Peptide Therapeutics Price by Type (2017-2022)
4.3.2 Global Protein and Peptide Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Protein and Peptide Therapeutics Sales by Application
5.1.1 Global Protein and Peptide Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Protein and Peptide Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Protein and Peptide Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Protein and Peptide Therapeutics Revenue by Application
5.2.1 Global Protein and Peptide Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Protein and Peptide Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Protein and Peptide Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Protein and Peptide Therapeutics Price by Application
5.3.1 Global Protein and Peptide Therapeutics Price by Application (2017-2022)
5.3.2 Global Protein and Peptide Therapeutics Price Forecast by Application (2023-2028)
6 Protein and Peptide Therapeutics Manufacturing Cost Analysis
6.1 Protein and Peptide Therapeutics Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Key Suppliers of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Protein and Peptide Therapeutics
6.4 Protein and Peptide Therapeutics Industrial Chain Analysis
7 Marketing Channel, Distributors and Customers
7.1 Marketing Channel
7.2 Protein and Peptide Therapeutics Distributors List
7.3 Protein and Peptide Therapeutics Customers
8 Protein and Peptide Therapeutics Market Dynamics
8.1 Protein and Peptide Therapeutics Industry Trends
8.2 Protein and Peptide Therapeutics Growth Drivers
8.3 Protein and Peptide Therapeutics Market Challenges
8.4 Protein and Peptide Therapeutics Market Restraints
9 Summary of research findings
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.2.3 Legal Disclaimer
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/north-america[2] https://www.marketresearchreports.com/countries/europe[3] https://www.marketresearchreports.com/countries/china[4] https://www.marketresearchreports.com/countries/japan[5] https://www.marketresearchreports.com/countries/global[6] https://www.marketresearchreports.com/healthcare[7] https://www.marketresearchreports.com/pharma-healthcare